Akero Therapeutics's total assets for Q4 2024 were $825.89M, an increase of 1.02% from the previous quarter. DE:0K4 total liabilities were $75.77M for the fiscal quarter, a -4.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.